跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHENEXPECT CD SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
PHENEXPECT CD SYRUP
Approved
THERAPEUTIC
PHENEXPECT CD SYRUP
ICM PHARMA PTE. LTD. (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Dec 3, 1991
Approval ID
4e135e01ff70b818
Company
ICM PHARMA PTE. LTD. (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
4e135e01ff70b818
Drug Name
PHENEXPECT CD SYRUP
Product Name
PHENEXPECT CD SYRUP
Approval Number
SIN06702P
Approval Date
1991-12-03
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05FB01
Atc Item Name
cough suppressants and mucolytics
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
AMMONIUM CHLORIDE
135 mg/5 ml
CODEINE PHOSPHATE
5.7 mg/5 ml
DIPHENHYDRAMINE HCl
12.5 mg/5 ml
AMMONIUM CHLORIDE
135 MG/5 ML
CODEINE PHOSPHATE
5.7 MG/5 ML
DIPHENHYDRAMINE HCL
12.5 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 3, 1991
Approval ID
4e135e01ff70b818
Type
Therapeutic
Back to HSA Approvals